We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $245M
1-Year Est. Return 23.8%
This Fund
S&P 500
This Quarter Est. Return
+8.85%
1 Year Est. Return
+23.8%
3 Year Est. Return
+70.62%
5 Year Est. Return
+83.19%
10 Year Est. Return
+679.91%
AUM
$147M
AUM Growth
+$12M
Cap. Flow
+$2.47M
Cap. Flow %
1.68%
Top 10 Hldgs %
36.98%
Holding
562
New
71
Increased
110
Reduced
100
Closed
84

Sector Composition

Rank Sector Weight
1 Technology 7.05%
2 Industrials 3.3%
3 Consumer Discretionary 3%
4 Financials 2.93%
5 Healthcare 2.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTVA icon
426
Corteva
CTVA
$50.9B
$807 ﹤0.01%
14
FTI icon
427
TechnipFMC
FTI
$29.5B
$804 ﹤0.01%
32
PPLI
428
People Inc
PPLI
$2.97B
$800 ﹤0.01%
18
ANF icon
429
Abercrombie & Fitch
ANF
$5.24B
$752 ﹤0.01%
6
CLF icon
430
Cleveland-Cliffs
CLF
$7.08B
$682 ﹤0.01%
30
-122
-80% -$2.42K
VIAV icon
431
Viavi Solutions
VIAV
$9.47B
$654 ﹤0.01%
72
PK icon
432
Park Hotels & Resorts
PK
$2.89B
$630 ﹤0.01%
36
AZEK
433
DELISTED
The AZEK Co
AZEK
$603 ﹤0.01%
+12
New +$523
FHN icon
434
First Horizon
FHN
$12B
$585 ﹤0.01%
38
+7
+23% +$100
POWL icon
435
Powell Industries
POWL
$7.59B
$569 ﹤0.01%
+12
New +$514
ASPN icon
436
Aspen Aerogels
ASPN
$510M
$563 ﹤0.01%
32
GOGL
437
DELISTED
Golden Ocean Group
GOGL
$557 ﹤0.01%
43
NTNX icon
438
Nutanix
NTNX
$17.4B
$555 ﹤0.01%
9
-3
-25% -$173
CUBI icon
439
Customers Bancorp
CUBI
$2.8B
$531 ﹤0.01%
10
+2
+25% +$105
SRPT icon
440
Sarepta Therapeutics
SRPT
$1.92B
$518 ﹤0.01%
4
CAMT icon
441
Camtek
CAMT
$7.67B
$503 ﹤0.01%
6
DLB icon
442
Dolby
DLB
$5.75B
$503 ﹤0.01%
+6
New +$496
ENOV icon
443
Enovis
ENOV
$1.42B
$500 ﹤0.01%
8
GDRX icon
444
GoodRx Holdings
GDRX
$1.3B
$497 ﹤0.01%
+70
New +$463
BEAM icon
445
Beam Therapeutics
BEAM
$2.77B
$496 ﹤0.01%
15
BROS icon
446
Dutch Bros
BROS
$8.66B
$495 ﹤0.01%
15
SPRY icon
447
ARS Pharmaceuticals
SPRY
$591M
$491 ﹤0.01%
48
+20
+71% +$149
X
448
DELISTED
US Steel
X
$489 ﹤0.01%
12
-79
-87% -$3.62K
EE icon
449
Excelerate Energy
EE
$1.11B
$465 ﹤0.01%
29
-142
-83% -$2.13K
SSYS icon
450
Stratasys
SSYS
$782M
$465 ﹤0.01%
40

Similar funds

C.M. Bidwell & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, C.M. Bidwell & Associates held 562 positions worth $147M, up 8.9% from $135M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

C.M. Bidwell & Associates's Q1 2024 filing shows 71 new, 110 increased, 100 reduced and 84 closed positions. Its largest new stake was Clorox: 2,166 shares worth $332K. The largest sale was Schwab US TIPS ETF, an estimated $697K.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 7% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • C.M. Bidwell & Associates's largest Q1 2024 buy was Clorox: 2,166 shares worth $332K.
  • C.M. Bidwell & Associates added most to Vanguard Short-Term Bond ETF in Q1 2024, an estimated $1.37M increase.
  • C.M. Bidwell & Associates's biggest Q1 2024 reduction was Schwab US TIPS ETF, cutting an estimated $697K.
  • C.M. Bidwell & Associates fully exited T-Mobile US in Q1 2024, selling an estimated $384K.
  • C.M. Bidwell & Associates's ten largest holdings make up 37% of its $147M portfolio in Q1 2024.
  • C.M. Bidwell & Associates opened 71 new positions and closed 84 in Q1 2024.
  • C.M. Bidwell & Associates's portfolio value rose 8.9% quarter-over-quarter to $147M.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2024, filed 14 May 2024.